Amplity’s Precision Medicine team provides expertise throughout the product life cycle, including but not limited to consultative support, medical affairs, commercial and Key Opinion Leader (KOL) networks. Our deep relationships with National and Regional Reference laboratories and University and Community pathologists create instant access to key players in the multidisciplinary process-pre and post-launch. Our colleagues amplify your diagnostic strategy and execution, optimizing your therapeutic launch.
We have supported successful Companion Diagnostic launches across several tumor types, disease states, and methodologies. As a result, we have first-hand evidence proving that when a diagnostic and therapy are aligned, therapeutic uptake is accelerated.
Interested in learning more? Click here for a case study
on how our Laboratory Science Liaisons supported testing a novel biomarker for a new Companion Diagnostic.